Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

2024 update in heart failure
Alberto Beghini, Antonio Maria Sammartino, Z. Papp, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

The Role of SGLT2-Inhibitors Across All Stages of Heart Failure and Mechanisms of Early Clinical Benefit: From Prevention to Advanced Heart Failure
Simone Pasquale Crispino, Andrea Segreti, Vincenzo Nafisio, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 608-608
Open Access | Times Cited: 1
BNP and NT-proBNP as prognostic biomarkers for the prediction of adverse outcomes in HFpEF patients: A systematic review and meta-analysis
Lama A. Ammar, Gaelle P. Massoud, Charbel Chidiac, et al.
Heart Failure Reviews (2024)
Closed Access | Times Cited: 4
Discovery of Titin and Its Role in Heart Function and Disease
Henk Granzier, Siegfried Labeit
Circulation Research (2025) Vol. 136, Iss. 1, pp. 135-157
Closed Access
Assessing the risk of heart failure in type 2 diabetes: a prediction algorithm to sustain the evaluation of NT-proBNP in primary care
Francesco Lapi, Ettore Marconi, Gerardo Medea, et al.
Endocrine (2025)
Closed Access
Evolution of the Quality of Care in Patients with Decompensated Heart Failure in a Venezuelan Hospital
Yaquelín Torres, Daniel Benítez, Zenaida Morillo, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 644-644
Open Access
Update on the Efficacy and Safety of Sodium–Glucose Co-Transporter 2 Inhibitors in Patients with Chronic Diseases: A Systematic Review and Meta-Analysis
I-Chia Liang, Hsun-Hao Chang, Yu-Jou Lai, et al.
Medicina (2025) Vol. 61, Iss. 2, pp. 202-202
Open Access
Acute Heart Failure and Non-Ischemic Cardiomyopathies: A Comprehensive Review and Critical Appraisal
Lina Manzi, Federica Buongiorno, Viviana Narciso, et al.
Diagnostics (2025) Vol. 15, Iss. 5, pp. 540-540
Open Access
Sodium-glucose co-transporter 2 inhibitors: a pleiotropic drug in humans with promising results in cats
Aline Bomfim Vieira, Sarah M. Cavanaugh, Bianca Torres Ciambarella, et al.
Frontiers in Veterinary Science (2025) Vol. 12
Open Access
Prognostic Impact of HFpEF in Hypertrophic Cardiomyopathy: A Machine Learning-Based Risk Stratification Study
Weijie Zhang, Huan Zhao, Zhu-Chang Tian, et al.
Research Square (Research Square) (2025)
Closed Access
Transition to Advanced Heart Failure: From Identification to Improving Prognosis
Nikolaos-Iason Tepetes, Christos Kourek, Adamantia Papamichail, et al.
Journal of Cardiovascular Development and Disease (2025) Vol. 12, Iss. 3, pp. 104-104
Open Access
Advances in cardiovascular pharmacotherapy. II. Ivabradine, an inhibitor of the hyperpolarization-activated cyclic nucleotide-gated channel
Paul S. Pagel, Dustin Hang, Julie K. Freed, et al.
Journal of Cardiothoracic and Vascular Anesthesia (2025)
Closed Access
Type 2 diabetes increases the risk of mortality and cardiovascular events in ischemic HFmrEF patients: a retrospective cohort study
Zhican Liu, Hailong Hu, Jianping Zeng, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Urocortin2 measurement for heart failure assessment
Kohei Inukai, Kazuya Miyashita, Kazuhiko Kotani, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
From bench to bedside: targeting ferroptosis and mitochondrial damage in the treatment of diabetic cardiomyopathy
Bin Liu, Qing Jin, Yi Sun, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Mortality and cardiorenal outcomes among heart failure patients with zinc deficiency: a multicenter retrospective cohort study of 8,290 patients
Yu‐Min Lin, Wan-Ling Tu, Kuo-Chuan Hung, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings
M. Lopez, Paolo Severino, Antonio Lax
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The Role of NtproBNP in Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction, Its Not Always a Seek and Hide Game
Christina Chrysochoou, K. I. Konstantinou, Kostas Tsioufis
(2024)
Open Access | Times Cited: 3
Translating evidence into practice: Managing electrolyte imbalances and iron deficiency in heart failure
Ryosuke Sato, Michael Koziolek, Stephan von Haehling
European Journal of Internal Medicine (2024)
Closed Access | Times Cited: 3
The Role of NT-proBNP Levels in the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction—It Is Not Always a Hide-and-Seek Game
Christina Chrysohoou, Konstantinos Konstantinou, Kostas Tsioufis
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 7, pp. 225-225
Open Access | Times Cited: 2
Beyond Medical Therapy—An Update on Heart Failure Devices
Luigi Falco, Fabio Valente, Aldo De Falco, et al.
Journal of Cardiovascular Development and Disease (2024) Vol. 11, Iss. 7, pp. 187-187
Open Access | Times Cited: 1
The Association of Weight Categories in Adolescence with Cardiovascular Morbidity in Young Adult Israeli Arabs—A Nationwide Study
Yulia Treister‐Goltzman, Dan Nemet, Idan Menashe
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5382-5382
Open Access | Times Cited: 1
Acute effects of empagliflozin on open-loop baroreflex function and urine output in streptozotocin-induced type 1 diabetic rats
Toru Kawada, Hiromi Yamamoto, Masafumi Fukumitsu, et al.
The Journal of Physiological Sciences (2024) Vol. 74, Iss. 1
Open Access | Times Cited: 1
Methionine sulfoxide reductase B2 protects against cardiac complications in diabetes mellitus
Seung Hee Lee, Suyeon Cho, Jong Youl Lee, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access
Moderne medikamentöse Therapie der chronischen Herzinsuffizienz
Can Öztürk
CardioVasc (2024) Vol. 24, Iss. 4, pp. 34-41
Closed Access
Navigating Hypertension in Hypertrophic Obstructive Cardiomyopathy: A Cardiovascular Conundrum
Sean W. Dooley, Usman A. Tahir, Jennifer Cluett
Hypertension (2024) Vol. 81, Iss. 10, pp. 2007-2011
Closed Access
Page 1 - Next Page

Scroll to top